Ningdong granule: A complementary and alternative therapy in the treatment of attention deficit/hyperactivity disorder

Psychopharmacology

Volumn 216, Issue 4, 2011, Pages 501-509

  Li, Ji Jun ^a   Li, Zai Wang ^b,c   Wang, Shu Zhen ^a   Qi, Fang Hua ^a   Zhao, Lin ^a   Lv, Hong ^a   Li, An Yuan ^a  

^a SHANDONG UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Alternative treatment; Attention deficit hyperactivity disorder; Ningdong granule; Paediatrics

Indexed keywords

CHINESE DRUG; DOPAMINE; HOMOVANILLIC ACID; METHYLPHENIDATE; NINGDONG; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ADOLESCENT; ALTERNATIVE MEDICINE; ANXIETY; ARTICLE; ATTENTION DEFICIT DISORDER; BLOOD ANALYSIS; BLOOD LEVEL; CHILD; CONTROLLED STUDY; DECREASED APPETITE; DIZZINESS; DOPAMINE BLOOD LEVEL; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; FECES ANALYSIS; HOMOVANILLIC ACID BLOOD LEVEL; HUMAN; HYPERSOMNIA; INCREASED APPETITE; KIDNEY FUNCTION; LIVER FUNCTION; MAJOR CLINICAL STUDY; NAUSEA; NERVOUSNESS; PRESCHOOL CHILD; PRIORITY JOURNAL; PSYCHOLOGICAL RATING SCALE; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SIDE EFFECT; SLEEP DISORDER; TEACHER AND PARENT ADHD RATING SCALE; URINALYSIS;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; COMPLEMENTARY THERAPIES; DOPAMINE; DOUBLE-BLIND METHOD; DRUGS, CHINESE HERBAL; FEMALE; HUMANS; MALE; METHYLPHENIDATE; TREATMENT OUTCOME;

EID: 79961166194     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-011-2238-z     Document Type: Article

References (62)

1. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. (DSM-IV). American Psychiatric Association, Washington, DC
2. S Akhondzadeh R Tavakolian R Davari-Ashtiani F Arabgol H Amini 2003 Selegiline in the treatment of attention deficit hyperactivity disorder in children: a double blind and randomized trial Prog Neuropsychopharmacol Biol Psychiatry 27 841 845 12921918 10.1016/S0278-5846(03)00117-9 1:CAS:528:DC%2BD3sXmt1KjtL8%3D (Pubitemid 36966767)
3. S Amiri MR Mohammadi M Mohammadi GH Nouroozinejad M Kahbazi S Akhondzadeh 2008 Modafinil as a treatment for attention-deficit/hyperactivity disorder in children and adolescents: a double blind, randomized clinical trial Prog Neuropsychopharmacol Biol Psychiatry 32 145 149 17765380 10.1016/j.pnpbp.2007. 07.025 1:CAS:528:DC%2BD1cXptlWruw%3D%3D
4. JK Anastasi LM Currie GH Kim 2009 Understanding diagnostic reasoning in TCM practice: tongue diagnosis Altern Ther Health Med 15 18 28 19472861
5. AF Arnsten 2006 Stimulants: therapeutic actions in ADHD Neuropsychopharmacology 31 2376 2383 16855530 10.1038/sj.npp.1301164 1:CAS:528:DC%2BD28XhtVyktLjP (Pubitemid 44607054)
6. I Baeza J Castro-Fornieles R Deulofeu E de la Serna J Goti J Salva M Bernardo 2009 Plasma homovanillic acid differences in clinical subgroups of first episode schizophrenic patients Psychiatry Res 168 110 118 19501918 10.1016/j.psychres.2008.04.011 1:CAS:528:DC%2BD1MXnsV2kt7k%3D
7. MH Bloch KE Panza A Landeros-Weisenberger JF Leckman 2009 Meta-analysis: treatment of attention-deficit/hyperactivity disorder in children with comorbid tic disorders J Am Acad Child Adolesc Psychiatry 48 884 893 19625978 10.1097/CHI.0b013e3181b26e9f
8. NI Bohnen R Cham 2006 Postural control, gait, and dopamine functions in parkinsonian movement disorders Clin Geriatr Med 22 797 812 17000336 10.1016/j.cger.2006.06.009 vi (Pubitemid 44416147)
9. DJ Brooks 2006 Dopaminergic action beyond its effects on motor function: imaging studies J Neurol 253 Suppl 4 IV8 15 16944357 10.1007/s00415-006-4003-5 (Pubitemid 44327092)
10. EF Coccaro SL Hirsch MA Stein 2007 Plasma homovanillic acid correlates inversely with history of learning problems in healthy volunteer and personality disordered subjects Psychiatry Res 149 297 302 17113158 10.1016/j.psychres. 2006.05.009 1:CAS:528:DC%2BD2sXnslGlug%3D%3D (Pubitemid 46108112)
11. S Cortese M Lecendreux BD Bernardina MC Mouren A Sbarbati E Konofal 2008 Attention-deficit/hyperactivity disorder, Tourette's syndrome, and restless legs syndrome: the iron hypothesis Med Hypotheses 70 1128 1132 18164140 10.1016/j.mehy.2007.10.013 1:CAS:528:DC%2BD1cXls12mtrc%3D
12. A Dhir SK Kulkarni 2007 Involvement of dopamine (DA)/serotonin (5-HT)/sigma (sigma) receptor modulation in mediating the antidepressant action of ropinirole hydrochloride, a D2/D3 dopamine receptor agonist Brain Res Bull 74 58 65 17683790 10.1016/j.brainresbull.2007.05.004 1:CAS:528: DC%2BD2sXosF2qurc%3D (Pubitemid 47187914)
13. GP Dupaul 1991 Parent and teacher ratings of ADHD symptoms: psychometric properties in a community based sample J Clin Child Psychol 20 245 253 10.1207/s15374424jccp2003-3
14. D Efron P Hazell V Anderson 2010 Attention deficit hyperactivity disorder in 2010 J Paediatr Child Health 10.1111/j.1440-1754.2010.01928.x
15. M Ernst LL Liebenauer D Tebeka PH Jons G Eisenhofer DL Murphy AJ Zametkin 1997 Selegiline in ADHD adults: plasma monoamines and monoamine metabolites Neuropsychopharmacology 16 276 284 9094145 10.1016/S0893-133X(96)00243-6 1:STN:280:DyaK2s3kvVShsA%3D%3D (Pubitemid 27146188)
16. AC Farias A Cunha CR Benko JT McCracken MT Costa LG Farias ML Cordeiro 2010 Manganese in children with attention-deficit/hyperactivity disorder: relationship with methylphenidate exposure J Child Adolesc Psychopharmacol 20 113 118 20415606 10.1089/cap.2009.0073
17. RL Findling MA Schwartz DJ Flannery MJ Manos 1996 Venlafaxine in adults with attention-deficit/hyperactivity disorder: an open clinical trial J Clin Psychiatry 57 184 189 8626348 1:CAS:528:DyaK28XmsFequ7g%3D (Pubitemid 26158852)
18. RD Freeman 2007 Tic disorders and ADHD: answers from a world-wide clinical dataset on Tourette syndrome Eur Child Adolesc Psychiatry 16 Suppl 1 15 23 17665279 10.1007/s00787-007-1003-7 (Pubitemid 47245229)
19. BC Galland EG Tripp BJ Taylor 2010 The sleep of children with attention deficit hyperactivity disorder on and off methylphenidate: a matched case-control study J Sleep Res 19 366 373 20050995 10.1111/j.1365-2869.2009. 00795.x
20. LS Goldman M Genel RJ Bezman PJ Slanetz 1998 Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association JAMA 279 1100 1107 9546570 10.1001/jama.279.14.1100 1:STN:280:DyaK1c3gs1KntA%3D%3D (Pubitemid 28177819)
21. LL Greenhill JM Swanson B Vitiello M Davies W Clevenger M Wu LE Arnold HB Abikoff OG Bukstein CK Conners GR Elliott L Hechtman SP Hinshaw B Hoza PS Jensen HC Kraemer JS March JH Newcorn JB Severe K Wells T Wigal 2001 Impairment and deportment responses to different methylphenidate doses in children with ADHD: the MTA titration trial J Am Acad Child Adolesc Psychiatry 40 180 187 11211366 10.1097/00004583-200102000-00012 1:STN:280:DC%2BD3M7ktFCntw%3D%3D (Pubitemid 32111021)
22. BL Handen AM Breaux J Janosky S McAuliffe H Feldman A Gosling 1992 Effects and noneffects of methylphenidate in children with mental retardation and ADHD J Am Acad Child Adolesc Psychiatry 31 455 461 1592777 10.1097/00004583-199205000-00011 1:STN:280:DyaK383ns1antw%3D%3D
23. M Kahbazi A Ghoreishi F Rahiminejad MR Mohammadi A Kamalipour S Akhondzadeh 2009 A randomized, double-blind and placebo-controlled trial of modafinil in children and adolescents with attention deficit and hyperactivity disorder Psychiatry Res 168 234 237 19439364 10.1016/j.psychres.2008.06.024 1:CAS:528:DC%2BD1MXoslGms7c%3D
24. KM Kahlig A Galli 2003 Regulation of dopamine transporter function and plasma membrane expression by dopamine, amphetamine, and cocaine Eur J Pharmacol 479 153 158 14612146 10.1016/j.ejphar.2003.08.065 1:CAS:528: DC%2BD3sXovVGntb8%3D (Pubitemid 37377884)
25. RG Klein B Landa JA Mattes DF Klein 1988 Methylphenidate and growth in hyperactive children. A controlled withdrawal study Arch Gen Psychiatry 45 1127 1130 3058088 1:STN:280:DyaL1M%2FmtFehuw%3D%3D
26. AL Krain FX Castellanos 2006 Brain development and ADHD Clin Psychol Rev 26 433 444 16480802 10.1016/j.cpr.2006.01.005
27. JV Lavigne T Cromley J Sprafkin KD Gadow 2009 The Child and Adolescent Symptom Inventory-Progress Monitor: a brief diagnostic and statistical manual of mental disorders, 4th edition-referenced parent-report scale for children and adolescents J Child Adolesc Psychopharmacol 19 241 252 19519259 10.1089/cap.2008.052
28. AY Li S Cong H Lu JJ Li L Zhao 2009 Clinical observation on treatment of Tourette syndrome by integrative medicine Chin J Integr Med 15 261 265 19688313 10.1007/s11655-009-0261-2
29. AY Li H Lv R Sun LL Lv XL Zhang P Wang 2009 Study on the pharmacodynamics of Ningdong granule for Tourette syndrome Journal of Chin Pediat r Integr Tradit West Med 1 48 50 10.3736/jcim20090107 (in Chinese)
30. AG Ludolph J Kassubek K Schmeck C Glaser A Wunderlich AK Buck SN Reske JM Fegert FM Mottaghy 2008 Dopaminergic dysfunction in attention deficit hyperactivity disorder (ADHD), differences between pharmacologically treated and never treated young adults: a 3,4-dihdroxy-6-[18F]fluorophenyl-l-alanine PET study Neuroimage 41 718 727 18424180 10.1016/j.neuroimage.2008.02.025
31. H Lv A Li H Ma F Liu H Xu 2009 Effects of Ningdong granule on the dopamine system of Tourette's syndrome rat models J Ethnopharmacol 124 488 492 19467315 10.1016/j.jep.2009.05.015
32. DE May CJ Kratochvil 2010 Attention-deficit hyperactivity disorder: recent advances in paediatric pharmacotherapy Drugs 70 15 40 20030423 10.2165/11530540-000000000-00000 1:CAS:528:DC%2BC3cXitFCqsLc%3D
33. A Nieoullon 2002 Dopamine and the regulation of cognition and attention Prog Neurobiol 67 53 83 12126656 10.1016/S0301-0082(02)00011-4 1:CAS:528:DC%2BD38Xlt1OitLc%3D (Pubitemid 34786170)
34. D Nutt K Demyttenaere Z Janka T Aarre M Bourin PL Canonico JL Carrasco S Stahl 2007 The other face of depression, reduced positive affect: the role of catecholamines in causation and cure J Psychopharmacol 21 461 471 17050654 10.1177/0269881106069938 1:CAS:528:DC%2BD2sXhtVWgurbP (Pubitemid 47106935)
35. RD Oades 2000 Differential measures of 'sustained attention' in children with attention-deficit/hyperactivity or tic disorders: relations to monoamine metabolism Psychiatry Res 93 165 178 10725533 10.1016/S0165-1781(00)00105-0 1:STN:280:DC%2BD3c7pt1Wguw%3D%3D (Pubitemid 30139483)
36. KJ Plessen JM Royal BS Peterson 2007 Neuroimaging of tic disorders with co-existing attention-deficit/hyperactivity disorder Eur Child Adolesc Psychiatry 16 Suppl 1 60 70 17665284 10.1007/s00787-007-1008-2 (Pubitemid 47245233)
37. SR Pliszka JT McCracken JW Maas 1996 Catecholamines in attention-deficit hyperactivity disorder: current perspectives J Am Acad Child Adolesc Psychiatry 35 264 272 8714313 10.1097/00004583-199603000-00006 1:STN:280: DyaK28zlslOktw%3D%3D (Pubitemid 26072283)
38. JB Prince TE Wilens J Biederman TJ Spencer R Millstein DA Polisner JQ Bostic 2000 A controlled study of nortriptyline in children and adolescents with attention deficit hyperactivity disorder J Child Adolesc Psychopharmacol 10 193 204 11052409 10.1089/10445460050167304 1:STN:280:DC%2BD3crgtlymuw%3D%3D
39. T Puumala J Sirvio 1998 Changes in activities of dopamine and serotonin systems in the frontal cortex underlie poor choice accuracy and impulsivity of rats in an attention task Neuroscience 83 489 499 9460757 10.1016/S0306-4522(97) 00392-8 1:CAS:528:DyaK1cXjslWqtA%3D%3D (Pubitemid 28062639)
40. G Reeves J Schweitzer 2004 Pharmacological management of attention-deficit hyperactivity disorder Expert Opin Pharmacother 5 1313 1320 15163276 10.1517/14656566.5.6.1313 1:CAS:528:DC%2BD2cXkt1GhtbY%3D (Pubitemid 38885792)
41. V Roessner A Becker T Banaschewski RD Freeman A Rothenberger 2007 Developmental psychopathology of children and adolescents with Tourette syndrome-impact of ADHD Eur Child Adolesc Psychiatry 16 Suppl 1 24 35 17665280 10.1007/s00787-007-1004-6 (Pubitemid 47245230)
42. BM Rowles RL Findling 2010 Review of pharmacotherapy options for the treatment of attention-deficit/hyperactivity disorder (ADHD) and ADHD-like symptoms in children and adolescents with developmental disorders Dev Disabil Res Rev 16 273 282 20981766 10.1002/ddrr.120
43. LA Ruocco MA de Souza Silva B Topic C Mattern JP Huston AG Sadile 2009 Intranasal application of dopamine reduces activity and improves attention in Naples High Excitability rats that feature the mesocortical variant of ADHD Eur Neuropsychopharmacol 19 693 701 19328660 10.1016/j.euroneuro.2009.02.005 1:CAS:528:DC%2BD1MXhtVKrsb3M
44. VA Russell 2003 Dopamine hypofunction possibly results from a defect in glutamate-stimulated release of dopamine in the nucleus accumbens shell of a rat model for attention deficit hyperactivity disorder-the spontaneously hypertensive rat Neurosci Biobehav Rev 27 671 682 14624811 10.1016/j.neubiorev. 2003.08.010 1:CAS:528:DC%2BD3sXptVelsr4%3D (Pubitemid 37414915)
45. E Ryden C Johansson K Blennow M Landen 2009 Lower CSF HVA and 5-HIAA in bipolar disorder type 1 with a history of childhood ADHD J Neural Transm 116 1667 1674 19756368 10.1007/s00702-009-0300-3 1:CAS:528:DC%2BD1MXhsVWqu7vK
46. T Sagvolden JA Sergeant 1998 Attention deficit/hyperactivity disorder-from brain dysfunctions to behaviour Behav Brain Res 94 1 10 9708834 10.1016/S0166-4328(97)00170-8 1:STN:280:DyaK1cznt1Gltw%3D%3D (Pubitemid 28352465)
47. B Salehi R Imani MR Mohammadi J Fallah M Mohammadi A Ghanizadeh AA Tasviechi A Vossoughi SA Rezazadeh S Akhondzadeh 2010 Ginkgo biloba for attention-deficit/hyperactivity disorder in children and adolescents: a double blind, randomized controlled trial Prog Neuropsychopharmacol Biol Psychiatry 34 76 80 19815048 10.1016/j.pnpbp.2009.09.026 1:CAS:528:DC%2BC3cXjvVSnsg%3D%3D
48. A Shenker 1992 The mechanism of action of drugs used to treat attention-deficit hyperactivity disorder: focus on catecholamine receptor pharmacology Adv Pediatr 39 337 382 1359740 1:STN:280:DyaK3s%2FntFequg%3D%3D
49. P Simon C Hemet C Ramassamy J Costentin 1995 Non-amphetaminic mechanism of stimulant locomotor effect of modafinil in mice Eur Neuropsychopharmacol 5 509 514 8998404 1:CAS:528:DyaK2MXhtVSgsbjL
50. CY So PW Leung SF Hung 2008 Treatment effectiveness of combined medication/behavioural treatment with Chinese ADHD children in routine practice Behav Res Ther 46 983 992 18692170 10.1016/j.brat.2008.06.007
51. H Soderstrom K Blennow A Manhem A Forsman 2001 CSF studies in violent offenders. I. 5-HIAA as a negative and HVA as a positive predictor of psychopathy J Neural Transm 108 869 878 11515752 10.1007/s007020170036 1:STN:280:DC%2BD3MvntVyhuw%3D%3D (Pubitemid 32692626)
52. H Soderstrom K Blennow A Manhem A Forsman 2001 CSF studies in violent offenders. II. Blood-brain barrier dysfunction without concurrent inflammation or structure degeneration J Neural Transm 108 879 886 11515753 10.1007/s007020170037 1:STN:280:DC%2BD3MvntVygsg%3D%3D (Pubitemid 32692627)
53. H Soderstrom K Blennow AK Sjodin A Forsman 2003 New evidence for an association between the CSF HVA:5-HIAA ratio and psychopathic traits J Neurol Neurosurg Psychiatry 74 918 921 12810780 10.1136/jnnp.74.7.918 1:STN:280:DC%2BD3s3otlOitw%3D%3D (Pubitemid 36782996)
54. MV Solanto 2002 Dopamine dysfunction in AD/HD: integrating clinical and basic neuroscience research Behav Brain Res 130 65 71 11864719 10.1016/S0166-4328(01)00431-4 1:CAS:528:DC%2BD38XhsFaksrs%3D (Pubitemid 34195322)
55. EJ Sonuga-Barke D Coghill T Wigal M DeBacker J Swanson 2009 Adverse reactions to methylphenidate treatment for attention-deficit/hyperactivity disorder: structure and associations with clinical characteristics and symptom control J Child Adolesc Psychopharmacol 19 683 690 20035586 10.1089/cap.2009. 0024
56. JA Staller SV Faraone 2007 Targeting the dopamine system in the treatment of attention-deficit/hyperactivity disorder Expert Rev Neurother 7 351 362 17425490 10.1586/14737175.7.4.351 1:CAS:528:DC%2BD2sXkt1Wqsr4%3D (Pubitemid 46655918)
57. DG Sukhodolsky JF Leckman A Rothenberger L Scahill 2007 The role of abnormal neural oscillations in the pathophysiology of co-occurring Tourette syndrome and attention-deficit/hyperactivity disorder Eur Child Adolesc Psychiatry 16 Suppl 1 51 59 17665283 10.1007/s00787-007-1007-3 (Pubitemid 47248499)
58. M Tomas Vila M Aleu Perez-Gramunt B Beseler Soto M Benac Prefasi J Pantoja Martinez I Pitarch Castellano 2010 Methylphenidate and sleep: results of a multicentre study on a population of children with attention deficit hyperactivity disorder An Pediatr (Barc) 73 78 83 10.1016/j.anpedi.2010.05.013 1:STN:280:DC%2BC3cjjsVGiug%3D%3D
59. ND Volkow JS Fowler GJ Wang YS Ding SJ Gatley 2002 Role of dopamine in the therapeutic and reinforcing effects of methylphenidate in humans: results from imaging studies Eur Neuropsychopharmacol 12 557 566 12468018 10.1016/S0924-977X(02)00104-9 1:CAS:528:DC%2BD38XptFeksbw%3D (Pubitemid 35414373)
60. HW Zhao F Qin YX Liu X Huang P Ren 2008 Antiapoptotic mechanisms of Chinese medicine formula, Guan-Xin-Er-Hao, in the rat ischemic heart Tohoku J Exp Med 216 309 316 19060445 10.1620/tjem.216.309
61. L Zhao AY Li H Lv FY Liu FH Qi 2010 Traditional Chinese medicine Ningdong granule: the beneficial effects in Tourette's disorder J Int Med Res 38 169 175 20233526 1:STN:280:DC%2BC3c7ovVelsA%3D%3D
62. X Zhuang RS Oosting SR Jones RR Gainetdinov GW Miller MG Caron R Hen 2001 Hyperactivity and impaired response habituation in hyperdopaminergic mice Proc Natl Acad Sci USA 98 1982 1987 11172062 10.1073/pnas.98.4.1982 1:CAS:528:DC%2BD3MXhsVWitrk%3D (Pubitemid 32165609)